CD8A and neoplasm: However, we also found that a higher dose of smTRAIL (8 mg/kg) could induce immunosuppression to inhibit both NK cell and CD8+ T-cell activation, which counteracts the tumor-killing effect caused by the induction of tumor apoptosis and even promotes the tumor growth of insensitive cells.